GLOBAL PH Share Price

Stocks

GBLP

US37945N1090

OTC Markets Traded
Market Closed - OTC Markets 20:59:56 05/06/2026 BST 5-day change 1st Jan Change
0.0801 USD +60.18% Intraday chart for GLOBAL PH 0.00% +60.20%
Current month+60.20%
1 month+60.20%
Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: GLOBAL PH

Market Cap 4.72M 4.12M 3.81M 3.57M 6.7M 446M 6.74M 45.24M 17.53M 219M 17.73M 17.35M 762M P/E 2006
-20.5x
P/E 2007 -4.23x
Enterprise Value 2.04M 1.78M 1.65M 1.54M 2.89M 193M 2.91M 19.56M 7.58M 94.82M 7.66M 7.5M 329M EV / Sales 2006
11.5x
EV / Sales 2007 4.95x
Free-Float
-
Yield 2006 *
-
Yield 2007 -
1 day+60.18%
Current month+60.20%
1 month+60.20%
3 months+60.20%
6 months+60.20%
Current year+60.20%
1 month 0.06
Extreme 0.0593
0.08
Current year 0.05
Extreme 0.05
0.08
1 year 0.05
Extreme 0.05
0.15
3 years 0.05
Extreme 0.05
0.35
5 years 0.05
Extreme 0.05
0.6
10 years 0.01
Extreme 0.008
0.9
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member - -

Financials

2006 2007
Net sales 2.38M 2.07M 1.92M 1.8M 3.37M 224M 3.39M 22.76M 8.82M 110M 8.92M 8.73M 383M 2.82M 2.46M 2.28M 2.13M 4M 266M 4.02M 27.01M 10.47M 131M 10.58M 10.36M 455M
Net income -1.23M -1.08M -997K -933K -1.75M -116M -1.76M -11.83M -4.58M -57.33M -4.63M -4.53M -199M -3.3M -2.88M -2.66M -2.49M -4.68M -311M -4.71M -31.6M -12.25M -153M -12.38M -12.12M -532M
Net Debt -2.68 -2.34 -2.16 -2.02 -3.8 -252.73 -3.82 -25.66 -9.94 -124.4 -10.05 -9.84 -431.95 -2.68 -2.34 -2.17 -2.03 -3.8 -252.99 -3.82 -25.68 -9.95 -124.52 -10.06 -9.85 -432.38
Logo GLOBAL PH
Global Pharmatech Inc is a company primarily engaged in the research, production and development of herbal medicine, bio-medicine, chemical medicine, traditional Chinese medicine (TCM) and dietary supplements. The Company’s main patented products include JUTAI SOFT CAPSULE, QINGXUAN ANTI-HYPERTENSION TABLET, YANREQING TABLET. The Company is also engaged in the manufacture and sales of other proprietary drugs, generics and dietary supplements used to treat symptoms ranging from headaches, coughing and dry mouth to infections and numbness of limbs. The Company also engages in the provision of biotechnology services, including research and development, testing, manufacturing drugs in liquid and solid dose forms, sales and marketing. The Company conducts its business in the domestic and overseas markets.
Employees
217
Sector
-
  1. Stock Market
  2. Stocks
  3. GBLP Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!